Protocols, Research Participants, and Safety in the Context of War
In collaboration with Ukraine Clinical Research Support Initiative (UCRSI)
This Webinar will be one hour in length followed by 30 minutes of member discussion where we welcome our attendees to turn on their camera, unmute their microphones, and share their thoughts/ask questions. We hope you can join the conversation about this important topic.
This webinar examines key questions that arise as sponsors, investigators, and regulatory authorities redefine pathways to ensure a favourable benefit-risk balance for participants of clinical trials in a rapidly evolving conflict situation.
In response to the rapidly evolving crisis in Ukraine and surrounding areas, DIA is offering this complimentary webinar to address ongoing uncertainty for both industry professionals and study participants in need. This session focuses on ethical considerations to prioritize, support, and protect study participants who have been impacted, and how to achieve the continuation/completion of clinical trials.
NOTE: This webinar is exclusive to DIA members only. To register, become a member, here.
Who should attend?
- Clinical Data Management
- Clinical Data Management/eClinical
- Clinical Research
- Clinical Safety/Pharmacovigilance
- Good Clinical Practice
- Medical Communications
- Patient Engagement
- Regulatory Affairs
- Research & Development
- Strategic Planning